Pulmonary Disease Caused by Mycobacterium xenopi: The First Case in Korea
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Mycobacterium xenopi is a nontuberculous mycobacterium (NTM) that rarely causes pulmonary disease in Asia. Here we describe the first case of M. xenopi pulmonary disease in Korea. A 66-year-old man was admitted to our hospital with a 2-month history of productive cough and hemoptysis. His past medical history included pulmonary tuberculosis 44 years earlier, leading to a right upper lobectomy. Chest X-ray upon admission revealed cavitary consolidation involving the entire right lung. Numerous acid-fast bacilli were seen in his initial sputum, and M. xenopi was subsequently identified in more than five sputum cultures, using molecular methods. Despite treatment with clarithromycin, rifampicin, ethambutol, and streptomycin, the infiltrative shadow revealed on chest X-ray increased in size. The patient's condition worsened, and a right completion pneumonectomy was performed. The patient consequently died of respiratory failure on postoperative day 47, secondary to the development of a late bronchopleural fistula. This case serves as a reminder to clinicians that the incidence of NTM infection is increasing in Korea and that unusual NTM are capable of causing disease in non-immunocompromised patients.
Abstract
Mycobacterium xenopi is a nontuberculous mycobacterium (NTM) that rarely causes pulmonary disease in Asia. Here we describe the first case of M. xenopi pulmonary disease in Korea. A 66-year-old man was admitted to our hospital with a 2-month history of productive cough and hemoptysis. His past medical history included pulmonary tuberculosis 44 years earlier, leading to a right upper lobectomy. Chest X-ray upon admission revealed cavitary consolidation involving the entire right lung. Numerous acid-fast bacilli were seen in his initial sputum, and M. xenopi was subsequently identified in more than five sputum cultures, using molecular methods. Despite treatment with clarithromycin, rifampicin, ethambutol, and streptomycin, the infiltrative shadow revealed on chest X-ray increased in size. The patient's condition worsened, and a right completion pneumonectomy was performed. The patient consequently died of respiratory failure on postoperative day 47, secondary to the development of a late bronchopleural fistula. This case serves as a reminder to clinicians that the incidence of NTM infection is increasing in Korea and that unusual NTM are capable of causing disease in non-immunocompromised patients.
참고문헌 (23)
- Diagnosis and treatment of disease caused by nontuberculous mycobacteria, "This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association", 156, pp.S1~S25 (1997)
- Koh WJ, "Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases:a Korean perspective", 20, pp.913~925 (2005)
- Jeon K, "Recovery rate of NTM from AFB smear- positive sputum specimens at a medical centre in South Korea", 9, pp.1046~1051 (2005)
- Koh WJ, "Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea", 129, pp.341~348 (2006)
- Jenkins PA, "Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients:five year follow-up of patients receiving standardised treatment", 97, pp.439~444 (2003)
- Parrot RG, "Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection", 69, pp.47~55 (1988)
- Parrot RG, "Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection", 69, pp.47~55 (1988)
- Simor AE, "The role of Mycobacterium xenopi in human disease", 129, pp.435~8 (1984)
- Simor AE, "The role of Mycobacterium xenopi in human disease", 129, pp.435~8 (1984)
- Yamazaki Y, "Two cases of pulmonary Mycobacterium xenopi infection", 41, pp.556~560 (2003)
- Yamazaki Y, "Two cases of pulmonary Mycobacterium xenopi infection", 41, pp.556~560 (2003)
- Kim H, "PCR restriction fragment length polymorphism analysis (PRA)-algorithm targeting 644 bp Heat Shock Protein 65 (hsp65) gene for differentiation of Mycobacterium spp", 62, pp.199~209 (2005)
- Kim H, "Differentiation of Mycobacterium species by analysis of the heat-shock protein 65 gene(hsp65)", 55, pp.1649~1656 (2005)
- Falkinham JO 3rd, "Epidemiology of infection by nontuberculous mycobacteria", 9, pp.177~215 (1996)
- Smith MJ, "Clinical review of pulmonary disease caused by Mycobacterium xenopi", 38, pp.373~7 (1983)
- Banks J, "Pulmonary infection with Mycobacterium xenopi:review of treatment and response", 39, pp.376~82 (1984)
- Wittram C, "Mycobacterium xenopi pulmonary infection:evaluation with CT", 22, pp.225~228 (1998)
- Contreras MA, "Pulmonary infection with nontuberculous mycobacteria", 137, pp.149~52 (1988)
- Banks J, "Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria", 42, pp.838~42 (1987)
- Lounis N, "Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice", 45, pp.3229~3230 (2001)
- Majoor CJ, "Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease", 59, pp.631~632 (2004)
- Schmitt H, "Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell- deficient patient with clarithromycin,rifabutin,and sparfloxacin", 29, pp.120~124 (1999)
- Lang-Lazdunski L, "Pulmonary resection for Mycobacterium xenopi pulmonary infection", 72, pp.1877~1882 (2001)